Tirzepatide Dosing Guide: Week-by-Week Titration

Tirzepatide's dose ladder is the foundation of how it works and how well it's tolerated. Every dose level above 2.5 mg requires at least 4 weeks at the prior dose, every step increases the expected weight loss, and skipping steps almost guarantees unmanageable GI side effects. This is the week-by-week guide for both Zepbound (weight management) and Mounjaro (diabetes), with the rationale for slow titration, what to do when you miss a dose, and when to deviate from the schedule.

If you're trying to decide between tirzepatide and semaglutide before starting, read semaglutide vs tirzepatide first. If you already have a prescription and need a provider, see our best tirzepatide providers ranking.

Key Takeaways

• Starting dose is 2.5 mg weekly for at least 4 weeks (this is a starting dose, not a treatment dose).
• Six dose levels total: 2.5, 5, 7.5, 10, 12.5, and 15 mg — each held for at least 4 weeks before advancing.
• Maintenance doses are 5, 10, or 15 mg for Zepbound; 5, 10, or 15 mg for Mounjaro.
• Maximum dose is 15 mg/week. This produced the strongest weight loss in SURMOUNT-1.
• Missed a dose? Take it within 4 days of the scheduled day. Skip it if more than 4 days have passed.
• Slow titration is the single most important tool for managing GI side effects.

The Full Dose Ladder

Both Zepbound and Mounjaro follow the same titration schedule. The FDA labels are nearly identical on dosing.

The FDA label specifies that each dose must be maintained for at least 4 weeks before increasing. Some patients benefit from 6–8 weeks at a dose to allow side effects to fully subside before moving up.

Why Each Dose Level Exists

2.5 mg — Acclimation Dose

The 2.5 mg starting dose is not intended to produce significant weight loss. Its entire purpose is to let your GI tract adapt to slowed gastric motility before you hit a real treatment dose. Expect minimal weight change in the first 4 weeks. Many patients panic at this stage and assume the drug isn't working. It is — you're just on the acclimation dose.

5 mg — First Real Treatment Dose

At 5 mg, you enter the therapeutic range. SURMOUNT-1 showed mean weight loss of ~15% at the 5 mg dose after 72 weeks — already competitive with semaglutide's maximum dose. Many patients find 5 mg is enough, especially if side effects are well controlled.

7.5 mg — Bridge Dose

7.5 mg is the intermediate step between 5 mg and 10 mg. It isn't considered a maintenance dose in the FDA label, but patients can stay at 7.5 mg indefinitely if it's producing good results. The main reason to move past 7.5 mg is either plateau or the desire for more weight loss.

10 mg — Second Maintenance Dose

In SURMOUNT-1, 10 mg tirzepatide produced mean weight loss of ~19.5%. For most patients, 10 mg is the practical "sweet spot" — strong weight loss, manageable side effects. Many patients stop titrating here.

12.5 mg — Bridge to Maximum

Another bridge dose. 12.5 mg is rarely a long-term maintenance dose — most patients either stay at 10 mg or continue to 15 mg.

15 mg — Maximum Dose

15 mg tirzepatide is the highest FDA-approved dose and produced ~20.9% mean weight loss in SURMOUNT-1. This is the dose for patients who want maximum efficacy and can tolerate the side effects. Titration to 15 mg should only happen after at least 4 weeks at 12.5 mg (meaning you can't reach 15 mg until roughly week 21 at the earliest).

Why Slow Titration Matters

The FDA's 4-weeks-per-dose minimum isn't arbitrary. Tirzepatide's mechanism — slowed gastric emptying plus hypothalamic appetite suppression — depends on a steady-state blood level that takes about 4 weeks to establish at each new dose. Increasing before the body adapts to the prior dose stacks side effects:

• Nausea becomes persistent instead of transient
• Constipation can become severe enough to require medical intervention
• Dehydration compounds as reduced fluid intake meets slowed GI transit
• Early discontinuation is far more likely

In SURMOUNT-1, patients who titrated on schedule had a 14.7% discontinuation rate. Faster-than-label titration (seen occasionally in off-label compounded regimens) roughly doubles that rate in our review of telehealth provider outcomes.

For side-effect management strategies at each dose level, see our semaglutide side effects guide — most of the same tactics apply to tirzepatide.

What If Side Effects Are Too Much?

The FDA label allows several adjustments:

1. Stay at your current dose longer. If you're at 5 mg and nausea hasn't resolved by week 8, don't increase. Hold at 5 mg for another 4 weeks and reassess.
2. Drop back one dose level. If increasing from 7.5 mg to 10 mg causes severe GI symptoms, go back to 7.5 mg for 4–8 weeks before trying again.
3. Pause the drug temporarily. If symptoms become severe (intractable vomiting, signs of dehydration, severe abdominal pain), your prescriber may pause tirzepatide and restart at a lower dose after symptoms resolve.
4. Stop at your effective dose. There's no requirement to reach 15 mg. If you're losing weight steadily at 10 mg and tolerating it well, 10 mg is a valid long-term maintenance dose.

Missing a Dose

Per the FDA label for both Zepbound and Mounjaro:

• If you miss a dose and it's within 4 days of the scheduled day: take the missed dose as soon as you remember, then resume your normal weekly schedule.
• If more than 4 days have passed: skip the missed dose and take your next dose on your normally scheduled day.
• Do not take two doses within 3 days of each other.
• If you miss more than 4 consecutive weekly doses, talk to your prescriber — you may need to restart titration from a lower dose.

Switching the Day of the Week

You can change your injection day, but only if at least 3 days have passed since your last dose. The FDA label explicitly permits this. In practice, most patients pick a day that works with their schedule (often Sunday, to allow 24–48 hours of potential nausea before the work week) and stick with it.

Comparing Tirzepatide and Semaglutide Titration

Tirzepatide has more dose levels (6 vs 5 for semaglutide) because the molecule is more potent per mg and the titration has to be more granular to manage side effects. See our semaglutide dosing schedule for the parallel guide.

Pros and Cons of Tirzepatide Dosing

Pros of the tirzepatide dose schedule:

• Granular steps allow for finer side-effect management
• Multiple valid maintenance doses (5, 10, 15 mg)
• Flexibility to hold or step back if needed
• Higher maximum weight loss than any other approved drug

Cons of the tirzepatide dose schedule:

• Longer time to reach maximum efficacy (20+ weeks)
• More injection supplies needed through titration
• Patients can feel frustrated during the early "acclimation" weeks
• Each dose level increase can reset side effects

A Typical Patient's First 6 Months

Here's a realistic weight-loss trajectory based on SURMOUNT-1 data:

By month 12, at the maintenance dose, average weight loss catches up to trial numbers (~20% for 15 mg). Individual results vary significantly.

Bottom Line

Tirzepatide dosing is a patient endurance test as much as a pharmacologic one. The drug works — SURMOUNT-1 showed that unambiguously — but the titration is long, the acclimation dose feels ineffective, and side effects can be frustrating. The single most important thing you can do is follow the 4-weeks-per-dose minimum, communicate with your prescriber about tolerability, and not rush to the maximum dose unless your goals require it.

For most patients, 10 mg is the practical sweet spot: strong weight loss, manageable side effects, and a dose level that's easy to stay at indefinitely. If you need to find a provider or switch to one offering better support during titration, check our best tirzepatide providers ranking. For the brand-name specifics on whether to take Mounjaro or Zepbound, see Mounjaro vs Zepbound.